Shining a spotlight on race & ethnicity in systemic AL amyloidosis

With an increasingly more diverse profile of patients diagnosed with AL amyloidosis, there is a need to better understand how this unique disease may affect various patient groups differently.

Author

Go to the profile of Andrew Staron

Andrew Staron

Hematology & Oncology Clinical Fellow, Boston University Medical Center

Contributing author

Go to the profile of Vaishali Sanchorawala

Vaishali Sanchorawala

MD, Boston University School of Medicine